We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.8B
AUM Growth
-$222M
Cap. Flow
-$287M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.23%
Holding
920
New
57
Increased
332
Reduced
337
Closed
91

Top Buys

Rank Stock Value
1
LCII icon
LCI Industries
LCII
+$19.9M
2
KWR icon
Quaker Houghton
KWR
+$19.1M
3
FORM icon
FormFactor
FORM
+$17.5M
4
AMSF icon
AMERISAFE
AMSF
+$16.5M
5
TKR icon
Timken Company
TKR
+$16.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.23%
2 Technology 19.83%
3 Financials 14.91%
4 Consumer Discretionary 12.13%
5 Healthcare 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNDT icon
451
Conduent
CNDT
$245M
$5.8M 0.05%
1,436,737
-385,730
-21% -$1.53M
TROX icon
452
Tronox
TROX
$999M
$5.78M 0.05%
573,603
+80,060
+16% +$974K
PROF
453
Profound Medical
PROF
$263M
$5.75M 0.05%
764,799
+195,501
+34% +$1.5M
NEWT icon
454
NewtekOne
NEWT
$423M
$5.71M 0.05%
447,461
-303,831
-40% -$4.12M
VSXY
455
Victoria's Secret
VSXY
$7.01B
$5.61M 0.05%
135,377
-91,090
-40% -$3.22M
CVGI icon
456
Commercial Vehicle Group
CVGI
$147M
$5.59M 0.05%
2,253,611
+93,805
+4% +$251K
CNXN icon
457
PC Connection
CNXN
$2.08B
$5.56M 0.05%
80,232
+1,442
+2% +$104K
LFMD icon
458
LifeMD
LFMD
$176M
$5.52M 0.05%
1,115,991
+214,950
+24% +$1.13M
HFWA icon
459
Heritage Financial
HFWA
$1.21B
$5.52M 0.05%
225,121
-45,048
-17% -$1.09M
INVE icon
460
Identive
INVE
$64.8M
$5.46M 0.05%
1,491,570
+117,827
+9% +$442K
UVSP icon
461
Univest Financial
UVSP
$1.22B
$5.38M 0.05%
182,451
-61,015
-25% -$1.81M
MPB icon
462
Mid Penn Bancorp
MPB
$976M
$5.38M 0.05%
186,617
-18,371
-9% -$568K
CTLP
463
DELISTED
Cantaloupe
CTLP
$5.35M 0.05%
563,000
+281,000
+100% +$2.56M
CMTL icon
464
Comtech Telecommunications
CMTL
$50.9M
$5.32M 0.05%
1,325,608
+336,310
+34% +$1.2M
ENVA icon
465
Enova International
ENVA
$6.31B
$5.3M 0.05%
55,322
-6,282
-10% -$599K
FC icon
466
Franklin Covey
FC
$243M
$5.29M 0.05%
140,793
+126,506
+885% +$4.86M
MRVI icon
467
Maravai LifeSciences
MRVI
$996M
$5.23M 0.05%
958,885
+50,107
+6% +$322K
PDFS icon
468
PDF Solutions
PDFS
$1.93B
$5.22M 0.05%
192,700
OPRX icon
469
OptimizeRx
OPRX
$118M
$5.2M 0.05%
+1,069,560
New +$5.98M
FOUR icon
470
Shift4
FOUR
$4.26B
$5.19M 0.05%
50,000
NMIH icon
471
NMI Holdings
NMIH
$3.3B
$5.16M 0.05%
140,288
+2,417
+2% +$93.9K
PANL icon
472
Pangaea Logistics
PANL
$493M
$5.15M 0.05%
960,102
+185,650
+24% +$1.12M
BHRB icon
473
Burke & Herbert Financial Services Corp
BHRB
$1.47B
$5.14M 0.05%
82,462
-13,317
-14% -$871K
ALOT icon
474
AstroNova
ALOT
$224M
$5.14M 0.05%
427,898
-6,300
-1% -$88.7K
ACTG icon
475
Acacia Research
ACTG
$426M
$5.1M 0.05%
1,174,641
+56,726
+5% +$257K

Similar funds

Royce & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Royce & Associates held 920 positions worth $10.8B, down 2% from $11B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Royce & Associates's Q4 2024 filing shows 57 new, 332 increased, 337 reduced and 91 closed positions. Its largest new stake was AMERISAFE: 305,361 shares worth $15.7M. The largest sale was Ziff Davis, an estimated $33.8M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q4 2024 buy was AMERISAFE: 305,361 shares worth $15.7M.
  • Royce & Associates added most to LCI Industries in Q4 2024, an estimated $19.9M increase.
  • Royce & Associates's biggest Q4 2024 reduction was Ziff Davis, cutting an estimated $33.8M.
  • Royce & Associates fully exited Carter's in Q4 2024, selling an estimated $13.1M.
  • Royce & Associates's ten largest holdings make up 9.2% of its $10.8B portfolio in Q4 2024.
  • Royce & Associates opened 57 new positions and closed 91 in Q4 2024.
  • Royce & Associates's portfolio value fell 2% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.